If Wyeth profits remained the same and all of their earnings were paid out as dividends then Wyeth stocks would earn 6.25%. This is greater than the earnings of any other company in the drugs industry. This is also very good in terms of the general market. With just moderate earnings growth and a slightly higher value in the market then stock holders will see a great increase.

The stock of most companies in the drugs industry have had high returns on their assets over the past five years. Compared to these companies Wyeth has had average returns on their assets throughout the last five years. In addition, Wyeth net profit margins have been average when compared to other companies in the drugs industry.

Most companies in the drugs industry have about twenty-five percent debt. Wyeth is much higher than the drugs industry average with about forty-two percent debt.

In the drugs industry there are many large competitors and Wyeth places about a medium-sized player. Other companies span both market caps and valuations. Wyeth stock is in the large-cap area with growth potential. Growth stocks are more risky but they have a higher return prospect.

Most drugs industry stock has had a steady increase in revenue and earnings throughout the past three years. Wyeth stock has seen similar growth however its earnings per share have fallen throughout the past three years compared to other companies. However, in the last year it has started doing better.

Analyst state that the earnings from Wyeth stocks are stable. Wyeth stocks have a low dividend yield which is not uncommon in the drugs industry. Most newer companies like Wyeth with potential growth opportunities have low dividend yields. Wyeth stock dividends have been very stable throughout the last five years.